Snowflake Stock Jumps 6% on New Palantir AI Partnership
Partnership links their data platforms so businesses can create AI applications faster and easier.
Already have an account? Sign in.
Partnership links their data platforms so businesses can create AI applications faster and easier.
A patient with highly active relapsing MS died 44 days after receiving BMS’s experimental CD19 CAR-T therapy zola-cel in an early-stage trial.
Bolt Biotherapeutics merges with Prana Therapies in a $120 million deal to advance PRA-216 through Phase 2 trials in asthma, COPD, and atopic dermatitis.
AbbVie’s Phase 3 HS data fell short of expectations, prompting two firms to downgrade Avalo Therapeutics and lower confidence in IL-1 approaches.
Be the first to know when deals break, stocks move, or biotech headlines hit.